bisbenzimidazole has been researched along with Sclerosis, Systemic in 2 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 1 |
| Kiechle, F | 1 |
| Schmitz, A | 1 |
| Guilly, MN | 1 |
| Trask, B | 1 |
| van den Engh, G | 1 |
2 other studies available for bisbenzimidazole and Sclerosis, Systemic
| Article | Year |
|---|---|
Hoechst 33342-induced apoptosis is associated with decreased immunoreactive topoisomerase I and topoisomerase I-DNA complex formation.
Topics: Animals; Apoptosis; Autoantibodies; Benzimidazoles; Bisbenzimidazole; Blotting, Western; Cell Line; | 2001 |
Immunofluorescent labeling of centromeres for flow cytometric analysis.
Topics: Animals; Antibodies; Bisbenzimidazole; Centromere; Chromomycins; Chromosomes; Cricetinae; Cricetulus | 1992 |